Advertisement
News
Advertisement

Recall: Spacelabs Healthcare Pulls Anesthesia Workstations over Excess CO2 Risk

Wed, 03/27/2013 - 4:33pm
Mass Device

The FDA puts its highest-risk label on Spacelabs Healthcare's anesthesia workstation recall over concerns that a defect resulting in excess carbon dioxide concentration in inhaled gas may lead to patient harm or even death.

Washington-based Spacelabs Healthcare recalled a slate of its Spacelabs BleaseSirius and BleaseFocus anesthesia workstations as well as certain absorbers contained in service kits over concerns that they may contain a defect which could result in excess carbon dioxide in the gas delivered to a patient.

The FDA slapped the recall with Class I status, generally reserved for the highest-risk device defects, over concerns that excess carbon dioxide inhalation "may cause serious adverse health consequences, including death."

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading